Veracyte
VCYT
250 hedge funds and large institutions have $2.14B invested in Veracyte in 2023 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 80 increasing their positions, 105 reducing their positions, and 20 closing their positions.
75% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 20
46% more call options, than puts
Call options by funds: $2.83M | Put options by funds: $1.95M
25% more capital invested
Capital invested by funds: $1.72B → $2.14B (+$425M)
6% more funds holding
Funds holding: 236 → 250 (+14)
1.23% more ownership
Funds ownership: 105.34% → 106.57% (+1.2%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
24% less repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 105
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$21.6M |
| 2 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$14.7M |
| 3 |
Man Group
London,
United Kingdom
|
+$10.4M |
| 4 |
BlackRock
New York
|
+$6.58M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$4.98M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$9.59M |
| 2 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$6.08M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$4.67M |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$4.06M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$3.55M |
VCYT Hedge Fund Activity: Q4 2023 in Review
250 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q4 2023, worth a combined $2.14B — up 25% from $1.72B a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new VCYT positions and 20 closed out — a net gain of 15 holders — while 80 added to existing stakes and 105 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $21.6M. The largest seller was Point72 Asset Management, cutting an estimated $9.59M.
- 250 institutional investors held Veracyte (VCYT) as of Q4 2023, up from 236 in Q3 2023.
- Funds reported $2.14B of Veracyte stock for Q4 2023, up 25% quarter-over-quarter.
- 35 funds opened new Veracyte positions in Q4 2023 and 20 closed out, a net change of +15 holders.
- The largest Veracyte buyer in Q4 2023 was Morgan Stanley, an estimated $21.6M added.
- The largest Veracyte seller in Q4 2023 was Point72 Asset Management, an estimated $9.59M sold.
Based on aggregated 13F filings for Q4 2023.